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Introduction
The demand for the supply of clean water is increasing due to the continuing human population growth (Loos et al., 2007) . However, population growth and urbanization is associated with a reduction in water quality with industrial and agricultural activities contributing to the contamination of water sources (Guillette and Crain, 2000; Sumpter, 2005; Falconer et al., 2006) . Some of these contaminants are endocrine disruptors that have the potential to cause adverse health effects in humans.
Endocrine disrupting chemicals (EDCs) can enter the aquatic environment via direct discharge into water, effluents from sewage treatment plants, leaching (e.g. leakage from septic tanks and landfill sites), storm water runoff and accidental spills (Slabbert et al., 2008; Burkhardt-Holm, 2010) . Many environmental EDCs are estrogenic and estrogenic activity was found at varying concentrations in raw and treated water in various countries, including South Africa (Slabbert et al., 2008; Burkhardt-Holm, 2010; Genthe et al., 2010; Manickum and John, 2014) . Natural and synthetic estrogens, bisphenol-A (BPA), nonylphenol (NP) and short chain phthalates are some of the substances that contribute to the estrogenic load in water bodies and may cause adverse effects in aquatic organisms (Kunz et al., 2015) . Natural hormones, including estrogens, can be released into the environment via sewage effluent and from such sources such as agricultural and pharmaceutical activities (Falconer et al., 2006; Slabbert et al., 2008; Burkhardt-Holm, 2010) .
Estrogenic potencies of natural and synthetic estrogens are three to seven orders of magnitude greater than the potencies of other EDCs, making them the major contributor to e strogenic activity in environmental water (Desbrow et al., 1998; 6 Tanaka et al., 2001; Nakada et al., 2004; Racz and Goel, 2010) . Although natural estrogens are essential for normal development and reproduction, natural and synthetic estrogens are also known human carcinogens (Metzler et al., 1998) .
BPA may be present in some plastics, polyvinyl chloride (PVC) products and thermal receipts (Biederman et al., 2010; Rochester, 2013) . These products are often disposed of in landfill sites. Compounds, like BPA, can enter waterways through leachate from landfill sites (Kawagoshi et al., 2003) . BPA exposure is associated with adverse reproductive and developmental effects, metabolic disease, disruption of thyroid function and immune disorders (Rochester, 2013) . NP is used in the manufacturing of industrial and household surfactants and plastics. It is introduced to the environment mainly through industrial effluents and wastewater discharges (Loyo-Rosales et al., 2004; Burkhardt-Holm, 2010) . In addition to the steroid hormones, NP may contribute substantially to the estrogenic activity in aquatic environments (Ternes et al., 1999b; Johnson et al., 2005; Galli and Braun, 2008) .
The endocrine disruptive effects of NP include feminization of aquatic organisms and decreased male fertility (Soares et al., 2008) .
Phthalates are used as plasticisers in PVC plastics and are found in numerous consumer products. Phthalates are not covalently bonded to the plastics in which they are used, and are therefore continuously being released from the products (Heudorf et al., 2007) . Contamination of waterways may therefore be through leachate from landfill sites (Burkhardt-Holm, 2010) . Phthalates are associated with increased adiposity and insulin resistance (Grun and Blumberg, 2009) , decreased levels of sex hormones (Pan et al., 2006) and other adverse effects on the human 7 reproductive system (Hauser and Calafat, 2005; Sax, 2010) as well as attention deficit hyperactivity disorder and reduced IQ scores in children (Cho et al., 2010) .
Di(2-ethylhexyl) adipate (DEHA) is used as an alternative to phthalates in flexible PVC products (Ghisari and Bonefeld-Jorgensen, 2009 ) and has been classified by the United States Environmental Protection Agency (USEPA) as a possible human carcinogen (USEPA, 1992) .
EDCs can potentially be found in drinking water if drinking water treatment processes are not effectively removing these environmental water contaminants from the source water. Water treatment process technology differs at different water treatment plants and various steps in the water treatment process can remove estrogenic activity to some degree (Slabbert et al., 2008; Burkhardt-Holm, 2010) .
Treatment options to remove EDCs include separation processes, adsorption and biological and chemical conversion (Chang et al., 2009) . Each treatment method has its own limitations and benefits to remove EDCs. Although water treatment processes can be effective in removing EDCs from drinking water, chemicals might also migrate from the water lines/pipes that transport water to distribution points and to the home, thereby adding to the contamination of the drinking water . NP, phthalate esters and BPA can migrate from reservoirs and pipes containing polyethylene plastic, epoxy resins or paints (Romero et al., 2002; Casajuana and Lacorte, 2003) .
Limited information is available on estrogenic activity and levels of EDCs in drinking water from South Africa. This study investigated the estrogenic activity in drinking water from various distribution points in Pretoria (City of Tshwane) and Cape Town,
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South Africa. The drinking water samples were also analysed for selected target chemicals that included natural and synthetic estrogens, BPA, NP, selected phthalates and DEHA, followed by a scenario based human health risk assessment.
Materials and Methods

Sample collection and extraction
Treated drinking water samples were collected seasonally over four sampling periods from two study areas, namely Pretoria (City of Tshwane) and Cape Town.
Both are larger, well-functioning municipalities, but in different geographical areas of South Africa. The main water distribution points in Pretoria and Cape Town were identified and ten representative sampling sites per city were selected. Samples were taken from selected distribution points and not from individual homes (i.e. not point of use). These points rather than points in private homes were selected in order to prevent the possibility of confounding factors in the form of the different types of piping used in private homes and to provide an indication of the quality of water supplied by the water service provider. Table 1 summarizes the treatment processes that were applied to the water from each distribution point. (Waters, 2009) . SPE cartridges were pre-conditioned with 5 mL 10% methanol in methyl tertiarybutyl ether (MtBE) (Sigma-Aldrich, St. Louis, MO, USA), followed by 3 mL methanol. The cartridges were equilibrated with 3 mL double-distilled water, before the samples were loaded (1 L/cartridge). The cartridges were washed with 3 mL 5% methanol in double-distilled water and dried. The samples were eluted from the cartridges using 6 mL 10% methanol in MtBE. Throughout the extraction procedure the flow rate was never allowed to exceed 10 mL/minute and care was taken not to let the cartridge run dry until the whole sample volume passed through the cartridge. Glass serological pipettes were used for all solvents and disposable serological pipettes were used for the samples. After elution, the solvent was evaporated to dryness at 37 °C under a gentle nitrogen stream. The sample residue was reconstituted in 1 mL HPLC grade ethanol (Merck, Darmstadt, Germany) for analysis in the bioassays (concentration factor of 1 000 x). A separate extract of each sample was derivatized for ultra-performance liquid chromatography-tandem mass spectrophotometry (UPLC-MS/MS) analysis. Reconstituted samples were stored at -20 °C.
Bioassays for estrogenic activity
Recombinant yeast estrogen screen (YES)
The YES bioassay was developed in the Genetics Department at Glaxo and is described in detail in Routledge and Sumpter (1996) . The genetically modified The detection limit of the yeast assay was calculated as the absorbance elicited by the solvent control plus three times the standard deviation. The E 2 standard curve was fitted (sigmoidal function, variable slope) using Graphpad Prism (version 4), and the estradiol equivalents (EEq) of water samples with three or more points above the detection limit were interpolated from the standard curve and corrected with the appropriate dilution factor for each sample.
T47D-KBluc reporter gene bioassay
The T47D-KBluc reporter gene bioassay was developed by the USEPA to screen environmental samples and chemicals for estrogenic and anti-estrogenic activities and is described in detail in Wilson et al. (2004) . The T47D-KBluc cells were purchased from the American Type Culture Collection (ATCC, Manassas, Virginia, USA). The assay was performed according to standard assay procedures (Wilson et al., 2004; De Jager et al., 2011 Recoveries obtained for this method were 104% for BPA; 64% for NP; 163% for DEHA; 167% for DBP; 102% for DEHP; 88% for E 2 ; 84% for E 1 and 89% for EE 2 .
The instrument and method details for UPLC-MS/MS analyses are available in the supplementary information (see A.1).
Human health risk assessment
A Human Health Risk Assessment was conducted to assess the potential human health impacts of the chemicals found in the tested water samples. The assessment Bioassay results were compared to the trigger value of 0.7 ng/L for estrogenic activity in drinking water suggested by Genthe et al. (2010) . If the trigger value is exceeded, possible adverse health effects are implicated and necessitate further investigation and testing of the water.
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The concentrations of the identified target chemicals were used to calculate the total dose a person may be exposed to. The computer programme Risk*Assistant was , meaning that the excess risk of developing cancer is deemed acceptable if ingestion of the substance results in one additional cancer case per hundred thousand of the population or less.
Results and discussion
Bioassays for estrogenic activity
None of the water extracts from the distribution points were above the detection limit in the YES bioassay. Although the YES bioassay has several advantages, including its robustness, lack of endogenous receptors that can interfere with the response of the cells, lower cost and uncomplicated bioassay procedure, yeast-based bioassays are less sensitive compared to human cell lines (Connolly et al., 2011; Kunz et al., 2015) . Estrogenic activity was also below the detection limit in drinking water from Brazil (Bergamasco et al., 2011) and Finland (Omoruyi and Pohjanvirta, 2015) using yeast based assays. The YES bioassay is therefore not as suitable for detection of low levels of estrogenic activity normally found in drinking water.
Estrogenic activity was detected in distribution point water using the T47D-KBluc bioassay, with EEq values ranging from 0.002 to 0.114 ng/L. The EEq values for each distribution point is summarized in Table 2 . None of the samples showed antiestrogenic activity. Estrogenic activity was also detected in drinking water from Italy (Maggioni et al., 2013) , Taiwan (Gou et al., 2016) , The Netherlands (Brand et al., 2013 ) and the US (Stanford et al., 2010) using mammalian cell line assays, with EEq values ranging from below the level of quantification to 1.3 ng/L (Table 4) .
Target chemical analyses
BPA, DEHA, DBP, DEHP, DINP, E 2 and E 1 were detected in distribution point water extracts from Pretoria and Cape Town. EE 2 was only detected at one distribution point in Pretoria (PTA08) in all four sampling periods. None of the Cape Town samples had EE 2 concentrations above the dl. NP was below the detection limit in all the extracts. The results of the target chemical analysis are summarized in Table 3 (the individual results for each sampling period is available in the supplementary information, see A.2). The presence of EDCs in drinking water could possibly be ascribed to either, the contamination of the source water and ineffective water treatment methodologies or, in the case of the plasticizers, migration from reservoir linings or plastic pipes at water distribution systems. Values were adjusted for the 1 000 x concentration of the samples during SPE BPA concentrations ranged from 0.01 to 28.83 ng/L and were detected in 90% of the Pretoria and 93% of the Cape Town samples. NP was below the detection limit in this study. Drinking water might contain residual amounts of chlorine from the disinfection procedure that reacts with NP to form diverse chlorinated byproducts (Hu et al., 2002) . This could explain why NP was not detected in the samples from this project. DEHA was detected in all the samples, with concentrations ranging from In this study, E 1 concentrations were at least twenty times higher than the E 2 concentrations. Compared to other estrogens, E 1 is excreted by humans and livestock at relatively high concentrations (Wise et al., 2011) . Furthermore, E 2 is biodegradable to E 1 in surface waters (Jurgens et al., 2002) and during sewage 22 treatment plant processes (Ternes et al., 1999a) , rendering E 1 one of the most frequently detected estrogens (Burkhardt-Holm, 2010).
More advanced treatment systems might be more effective at removing EDCs from drinking water, however, it is not always a viable option due to much higher operating costs (Racz and Goel, 2010) . Strategies to limit source contamination and effectively remove EDCs from source water are also recommended and may include the development of more effective water treatment technologies and public awareness campaigns (e.g. to reduce the use of and recycle plastic products and to dispose of unused pharmaceuticals in a responsible manner).
When comparing the chemical and bioassay results, EEq values were much lower than expected. For example, for PTA03 in October 2013 the E 1 concentration was 3.41 ng/L. Taking into account the relative potency of E 1 in the T47D-KBluc assay (0.46), an EEq of at least 1.57 ng/L was expected. However, the EEq for this sample was only 0.016 ng/L. The results indicate that antagonists might be present in the water samples. On the other hand, estrogenic activity was detected in some of the samples that were below the detection limit for the estrogens E 1 , E 2 and EE 2 . As the concentrations of BPA were below the concentrations expected to react in the bioassays, other chemicals or pharmaceuticals with estrogenic activity might be present in those samples. A broad chemical screening is therefore recommended to identify other chemicals/pharmaceuticals that may be present in the water samples. Table 4 presents a comparison of the estrogenic activity and levels of the target chemicals in this study to the activity and concentrations found in drinking water from 23 other countries. From the table, it is clear that BPA, NP, DEHA, phthalates and natural and synthetic estrogens are present in drinking water worldwide at a wide range of concentrations. Very few studies assessed drinking water for DINP, but this phthalate was detected in drinking water from this study as well as in drinking water from eastern China (Shi et al., 2012) . It is therefore recommended to include DINP when screening environmental or drinking water samples for phthalates.
Human health risk assessment
When analysing water samples using bioassays, trigger values are useful to judge whether further investigation is needed. Exceeding the trigger value does not necessarily mean that a health effect is expected, but further investigation is needed to identify substances responsible for the activity and could ultimately lead to a full risk assessment (Brand et al., 2013) . In this study, none of the samples were above the 0.7 ng/L trigger value for estrogenic activity in drinking water proposed by Genthe et al. (2010) .
For the health risk assessment 95 th percentiles were used as 'reasonable maximum' values to determine the risks associated with the consumption of distribution point water. The health risk assessment is summarised in (Bergamasco et al., 2011) Brazil (Piracicaba city) Torres et al., 2015) Canada ( Overall, this study indicated acceptable human health and carcinogenic risks associated with exposure to BPA, phthalates and estrogenic compounds through the consumption of distribution point water. EDCs in drinking water were also below the levels expected to have adverse health effects in Spain (Dominguez-Morueco et al., 2014), China (Liu et al., 2015) and Portugal (Santana et al., 2014) . Although this study indicated an acceptable human health and carcinogenic risk associated with the consumption of the distribution point water, it should be kept in mind that this study only focussed on selected target chemicals. Other hazardous chemicals, not 
Conclusions
Due to their ubiquity in the environment and endocrine disruptive activity, the potential impact of EDCs on public health is a reason for concern. This study revealed the presence of BPA, phthalates, DEHA and estrogenic hormones in distribution point water from Pretoria and Cape Town, South Africa. The estrogenic activity and levels of target chemicals were comparable to the levels found in other countries.
The presence of EDCs in drinking water can be ascribed to the contamination of the source water and ineffective water treatment methodologies or migration from reservoir linings or plastic pipes at water distribution systems. E 1 in Pretoria distribution point samples posed the highest potential health risk, but overall this 29 study indicated acceptable human health and carcinogenic risks associated with the consumption of distribution point water from Pretoria and Cape Town.
Due to the fact that EDCs were frequently detected in Pretoria and Cape Town distribution point water, a monitoring strategy is recommended that can act as an early warning system. Other municipalities should also be assessed and assays for androgenic and thyroid activity should be included. Strategies to limit source contamination and effectively remove EDCs from source water are also recommended.
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